Pulse Medex

Dyronib 20mg Tablet is used in the treatment of blood cancer (chronic myeloid leukaemia). It is used in patients whose disease could not be treated with other medications for leukaemia or who cannot take these medications because of side effects.

Dyronib 70mg Tablet is an anticancer medication containing Dasatinib, a tyrosine kinase inhibitor (TKI) used to treat Philadelphia chromosome-positive () Chronic Myeloid Leukemia (CML) and Acute Lymphoblastic Leukemia (ALL). It works by blocking abnormal proteins that drive cancer cell multiplication.

Dasatinib 50 mg tablet is a tyrosine-kinase inhibitor used as a targeted cancer therapy for Philadelphia chromosome-positive (Ph+) Chronic Myeloid Leukemia (CML) and Acute Lymphoblastic Leukemia (ALL). It works by blocking abnormal proteins that cause cancer cells to multiply. It is taken orally, typically once daily, with or without food.

Dyronib 20mg tablets (containing dasatinib) are a tyrosine kinase inhibitor used to treat adults and children (aged 1+ year) with Philadelphia chromosome-positive (